ASR Vermogensbeheer N.V. bought a new stake in Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,403 shares of the technology company’s stock, valued at approximately $375,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. ST Germain D J Co. Inc. bought a new position in Celestica in the second quarter valued at about $37,000. Wolff Wiese Magana LLC grew its position in Celestica by 45.6% in the second quarter. Wolff Wiese Magana LLC now owns 364 shares of the technology company’s stock valued at $57,000 after acquiring an additional 114 shares during the last quarter. ORG Partners LLC bought a new position in Celestica in the first quarter valued at about $29,000. Center for Financial Planning Inc. bought a new position in Celestica in the first quarter valued at about $30,000. Finally, Oakworth Capital Inc. bought a new position in Celestica in the second quarter valued at about $73,000. Institutional investors own 67.38% of the company’s stock.
Celestica Price Performance
Celestica stock opened at $234.08 on Friday. The stock’s 50 day moving average is $219.11 and its 200 day moving average is $151.41. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.44 and a quick ratio of 0.86. The firm has a market cap of $26.93 billion, a P/E ratio of 50.67 and a beta of 1.88. Celestica, Inc. has a one year low of $52.25 and a one year high of $261.83.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on CLS. UBS Group reiterated a “neutral” rating and issued a $208.00 target price (up previously from $101.00) on shares of Celestica in a research report on Wednesday, July 30th. Barclays boosted their price target on Celestica from $146.00 to $220.00 and gave the stock an “overweight” rating in a report on Wednesday, July 30th. TD Cowen restated a “hold” rating and set a $238.00 price target on shares of Celestica in a report on Friday. JPMorgan Chase & Co. boosted their price target on Celestica from $225.00 to $295.00 and gave the stock an “overweight” rating in a report on Monday, September 8th. Finally, CICC Research initiated coverage on Celestica in a report on Tuesday, August 19th. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $207.38.
Check Out Our Latest Research Report on CLS
Celestica Profile
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Further Reading
- Five stocks we like better than Celestica
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- Best Energy Stocks – Energy Stocks to Buy Now
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Conference Calls and Individual Investors
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.